Parkman Healthcare Partners LLC / DC4
Parkman Healthcare Partners LLC’s Dexcom Inc Position
Does Parkman Healthcare Partners LLC own Dexcom Inc (DC4)? Yes — 689.8K shares worth $43M (+4.47% of its 13F portfolio) as of Q1 2026, up from 587.5K shares the prior filed quarter.
Position Value
$43M
Q1 2026
Shares
689.8K
% of Portfolio
+4.47%
Quarters Held
26
currently held
Position History DC4
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 689.8K | $43M | +4.47% |
| Q4 2025 | 587.5K | $39M | +3.71% |
| Q3 2025 | 171.6K | $12M | +1.20% |
| Q2 2025 | 225.9K | $20M | +2.27% |
| Q1 2025 | 130.4K | $9M | +1.06% |
| Q4 2024 | 78.5K | $6M | +0.81% |
| Q3 2024 | 70.6K | $5M | +0.60% |
| Q2 2024 | 156.9K | $18M | +2.38% |
| Q1 2024 | 171.7K | $24M | +2.92% |
| Q4 2023 | 225.6K | $28M | +3.94% |
| Q3 2023 | 265.5K | $25M | +4.54% |
| Q2 2023 | 85.1K | $11M | +1.90% |
| Q1 2023 | 78.9K | $9M | +1.99% |
| Q4 2022 | 62.7K | $7M | +1.89% |
| Q3 2022 | 40.4K | $3M | +0.92% |
| Q2 2022 | 34.8K | $3M | +0.96% |
| Q1 2022 | 12.7K | $7M | +1.91% |
| Q4 2021 | 32.9K | $18M | +3.90% |
| Q3 2021 | 45.5K | $25M | +6.29% |
| Q2 2021 | 50.5K | $22M | +4.71% |
| Q1 2021 | 37.7K | $14M | +3.15% |
| Q4 2020 | 41.5K | $15M | +3.93% |
| Q3 2020 | 29.6K | $12M | +3.23% |
| Q2 2020 | 32.6K | $13M | +3.72% |
| Q1 2020 | 32.0K | $9M | +4.00% |
| Q4 2019 | 35.0K | $8M | +2.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of DC4.